Intravenous alteplase for ischaemic stroke

Lancet. 2007 Jan 27;369(9558):249-50. doi: 10.1016/S0140-6736(07)60120-2.
No abstract available

Publication types

  • Comment

MeSH terms

  • Aged
  • Cerebral Hemorrhage / chemically induced
  • Drug-Related Side Effects and Adverse Reactions
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / adverse effects
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Injections, Intravenous
  • Multicenter Studies as Topic
  • Patient Selection
  • Randomized Controlled Trials as Topic
  • Stroke / drug therapy*
  • Stroke / mortality
  • Tissue Plasminogen Activator / administration & dosage
  • Tissue Plasminogen Activator / adverse effects
  • Tissue Plasminogen Activator / therapeutic use*

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator